“Pfizer Vaccine Partially Prevents Infection with Omicron”

A study has found that a Pfizer vaccine provides partial infection protection for Omicron.

According to Bloomberg News on the 7th local time, the African Health Research Institute in South Africa conducted an experiment to measure the effectiveness of two doses of Pfizer’s vaccine. It has been confirmed that it is reduced by one-fourth.

Neutralizing antibodies prevent the virus from penetrating into cells, forming immunity.

However, research director Alex Segal said the loss of immunity was “vigorous, but not complete.” “There will be an increase in cases of the virus breaking through immunity, but the booster shot will probably reduce the risk of infection, especially severe seriousness.”

“People who have not received the booster shot should be vaccinated, and those who have been infected should be vaccinated,” he said.

Bloomberg News also commented on the findings of the study that Pfizer vaccine booster shots could help prevent infection with Omicron.

The World Health Organization has warned that Omicron could increase the contagiousness of the coronavirus and fuel a serious epidemic.

This is the first time that the protective effect of a Pfizer vaccine against Omicron has been reported.

The research institute conducted this study by measuring the concentration of antibodies that block the novel coronavirus using the plasma of about 10 people about a month after receiving the second dose of the Pfizer vaccine.

Experts believe that research like this will help determine how effective existing vaccines are at blocking Omicron.

The institute explained that this study is only early results, and that the results of Omicron’s exact vaccine evasion level may change.

After Omicron was discovered in South Africa on the 25th of last month, about 450 researchers around the world have been conducting similar research by isolating Omicron from samples of infected people and culturing them in a laboratory.